This 2022 correction pertains to the original article discussing the UroLift implant, a minimally invasive treatment for benign prostatic hyperplasia (BPH). The UroLift system employs small implants to retract prostatic tissue, thereby relieving urethral obstruction without cutting or removing tissue. This approach offers rapid symptom relief and preserves sexual function.
